上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1328Please respect copyright.PENANAYtIT4FQPfh
1328Please respect copyright.PENANAxRuFOCq4Eq
上集:https://www.penana.com/article/4711251328Please respect copyright.PENANAgWYbGyvpdw
1328Please respect copyright.PENANAVcBfFn0iJi1328Please respect copyright.PENANA1ks1QLKdhM
1328Please respect copyright.PENANA4YbzMk6A4S
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1328Please respect copyright.PENANAfdJTip2suv
1328Please respect copyright.PENANAzLHoUWRyO4
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1328Please respect copyright.PENANA1rb2oRymLT
1328Please respect copyright.PENANAcqcNyPcZRn
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1328Please respect copyright.PENANANI6AWAenwp
1328Please respect copyright.PENANA0h0xclhyos1328Please respect copyright.PENANALCOvZhaTkX
1328Please respect copyright.PENANA0pAxeyOyfT
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1328Please respect copyright.PENANA2VHzvTysD5
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1328Please respect copyright.PENANA4tNqvngtx4
1328Please respect copyright.PENANA4XzfOFa3KR
忘記甚麼是Neoantigen的話,可重溫上一集。1328Please respect copyright.PENANAR8YxJqeUNv
1328Please respect copyright.PENANARYB4eTA2Px
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1328Please respect copyright.PENANADiVZyFANqj
1328Please respect copyright.PENANAAr0JffhXgi
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1328Please respect copyright.PENANASoOJDa0xRt
1328Please respect copyright.PENANA3uJdokJryA1328Please respect copyright.PENANAnWL2XX21hI
1328Please respect copyright.PENANAo3bo2Ro00y
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1328Please respect copyright.PENANAqN9TTJbljK
1328Please respect copyright.PENANAIM6cX2KP6F
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1328Please respect copyright.PENANAtMwpC34331
1328Please respect copyright.PENANAYhX84kdP8B
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1328Please respect copyright.PENANAasWVNAFbSb1328Please respect copyright.PENANA5t8vQvxxQW
1328Please respect copyright.PENANAc3X73PVsKK
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1328Please respect copyright.PENANAeNGzopgYK0
1328Please respect copyright.PENANAj7z3CPGTQO
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1328Please respect copyright.PENANAKXaUOAiXys1328Please respect copyright.PENANAuZe4JvVAcm
1328Please respect copyright.PENANAo6EuQJGf4e
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1328Please respect copyright.PENANAIIKROGUe6H
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1328Please respect copyright.PENANAkhTDpEcwuK
1328Please respect copyright.PENANADPinsoEd9k
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1328Please respect copyright.PENANABNK8KShn0i
1328Please respect copyright.PENANAMm69kXi6oC
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1328Please respect copyright.PENANALQJGzOqI8A
1328Please respect copyright.PENANAt5QsxumsG5
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1328Please respect copyright.PENANADZz5W7602K
1328Please respect copyright.PENANAkSHCwb29tN
1328Please respect copyright.PENANAibDXb5K4Kk
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1328Please respect copyright.PENANALwzIfVzhTM
1328Please respect copyright.PENANAPqhp0jVY7r
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1328Please respect copyright.PENANARNQITXME1B
1328Please respect copyright.PENANA68XgI2Tb1Q
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1328Please respect copyright.PENANA9Dos8pFHhR
1328Please respect copyright.PENANAuybGsgytDk
Link:1328Please respect copyright.PENANA2Jv2Bngrvm
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1328Please respect copyright.PENANAfZjTkEHMI0
1328Please respect copyright.PENANAgdOQUPcdrD
1328Please respect copyright.PENANAcarboYu8kQ
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1328Please respect copyright.PENANACUvARqCYJZ